CHICAGO, IL — November 18, 2026 — Lynn Sage Breast Cancer Foundation won the Collaboration Award at the 25th annual Chicago Innovation Awards for the Chicago Breast Cancer Research Consortium, a first-of-its-kind initiative uniting four Chicago-area healthcare institutions to accelerate breast cancer research and expand patient access to clinical trials.
The award was announced on November 17 at the Chicago Innovation Awards ceremony at the UIC Forum, recognizing organizations whose innovative ideas, products, and services are making a meaningful impact across the Chicago region. More than 350 organizations were nominated for this year’s awards.
Launched in 2024 by Lynn Sage, the Consortium brings together UChicago Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Medicine, RUSH MD Anderson Cancer Center, and Endeavor Health to overcome institutional barriers and advance promising breast cancer research. Endeavor Health joined in October 2026 as the fourth partner, expanding the Consortium’s reach across the Chicago region.
Rather than conducting research independently, participating institutions work together to develop and conduct clinical trials, share resources and expertise, and accelerate the translation of scientific discoveries into new treatment options for patients.
The Consortium represents a new model for breast cancer research; one that puts collaboration ahead of competition and patients at the center of progress.
“Some of the most meaningful breakthroughs happen when we challenge the way things have always been done,” said Kirstin Chernawsky, Executive Director of Lynn Sage Breast Cancer Foundation. “The Chicago Breast Cancer Research Consortium is built on a simple but powerful idea: we can accomplish more together than we can alone. By bringing four leading institutions to the same table, we’re breaking down barriers, accelerating research, and bringing clinical trials closer to the patients who need them. This recognition belongs to the physicians, researchers, and patients, and partners making that possible.”
Breaking Down Barriers to Advance Breast Cancer Research
Led by Principal Investigator Dr. Rita Nanda and Consortium Chief Operating Officer Dr. Nan Chen of UChicago Medicine, the Consortium is creating a more connected and efficient research ecosystem across Chicagoland.
Through a shared governance structure, coordinated research infrastructure, and collaborative trial development, the Consortium enables researchers to pursue promising ideas across multiple institutions, reach more diverse patient populations, and generate findings that can inform future treatments.
The Consortium is also working to make clinical trials more accessible. Patients can participate in trials through their local healthcare institutions while staying with the physicians and care teams they know and trust. A dedicated Patient Support Fund helps cover practical barriers such as transportation, childcare, and other needs that can keep patients from participating in clinical trials.
Since launching the initiative in 2024, Lynn Sage has committed $1.8 million to the Consortium’s research and infrastructure. The Consortium’s growing portfolio of clinical trials ranges from better therapies for advanced disease to managing treatment-related side effects and improving patients’ quality of life.
Recognizing the Power of Collaboration
“The Chicago region leads the charge in innovation across many industries,” said Luke Tanen, President and CEO of Chicago Innovation. “The 2026 winners are solving unmet needs and making an impact in business services, consumer products, quantum, AI, food and beverage, healthcare, education, manufacturing, science, finance, legal, sustainability, workforce development and housing.”
For Lynn Sage, the recognition reinforces the Foundation’s longstanding belief that bold ideas and meaningful collaboration can transform breast cancer care. By investing in promising research, connecting leading institutions, and removing barriers to participation, Lynn Sage and its partners are building a model that extends beyond any one institution and moving us closer to a world without breast cancer.
About Lynn Sage Breast Cancer Foundation
The Lynn Sage Breast Cancer Foundation is a Chicago-based nonprofit committed to
eradicating breast cancer. Since 1985, we have raised more than $50 million to invest in
research, education, and clinical trials – supporting the work of both early-career and
established clinicians and researchers driven to find breakthroughs in breast cancer
prevention, detection, and treatments. Through the powerful combination of innovation and hope, we aim to end breast cancer for everyone. Learn more at lynnsage.org.
About the Chicago Innovation Awards
Established in 2002, the Chicago Innovation Awards celebrate the most innovative new products, services, and organizations in the Chicago region. The awards recognize innovators across industries whose ideas are creating meaningful impact and helping shape the region’s future. Learn more at chicagoinnovation.com.

Media Contact
Beth Heller | beth@mharris.com | 312.953.5879